The neurotechnology industry contains three sectors: neurodiagnostics, neuropharmaceuticals and neurodevices. The neurodevice sector includes medical devices, electronic implants and information technology solutions to treat neurological illnesses and psychiatric disorders.

Neurodevices such as cochlear implants for the hearing impaired and neurostimulation devices for the treatment of pain have already improved the quality of life for hundreds of thousands of individuals, their further potential applicability to a broad range of neurological disorders such as stroke, paralysis, Parkinson's disease, and epilepsy will drive substantial growth over the next decade.